- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRK
Recent news which mentions MRK
An undiscovered universe of stocks is trading at ‘near generational lows,’ asset manager says
April 27, 2023
From MarketWatch
The 7 Best Stocks From Schwab’s Dividend ETF
April 26, 2023
From InvestorPlace
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
From Motley Fool
From Motley Fool
3 Pharma Stocks That Could See a Surge in Demand in 2023
April 24, 2023
From InvestorPlace
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
April 21, 2023
From Benzinga
Why Prometheus Biosciences Stock Is Skyrocketing This Week
April 20, 2023
From Motley Fool
Why Shares of Bellus Health Skyrocketed This Week
April 20, 2023
From Motley Fool
Why Madrigal Pharmaceuticals Stock Gained 20% This Week
April 20, 2023
From Motley Fool
From Motley Fool
From Motley Fool
From Benzinga
From Motley Fool
Why BELLUS Health Stock Is Rocketing Higher Today
April 18, 2023
From Motley Fool
From Benzinga
Tesla, Windtree Therapeutics, Enovix Corp, Moderna, Blackboxstocks: Why These 5 Stocks Are Drawing Investors' Attention Today
April 17, 2023
From Benzinga
These 2 Stocks Were Monday's Big Disappointments
April 17, 2023
From Motley Fool
These 3 Nasdaq Stocks Are on Fire Today: Here's Why
April 17, 2023
From Motley Fool
Why Shares of Prometheus Biosciences Are Soaring Monday
April 17, 2023
From Motley Fool
Merck’s $10.8 billion takeover of Prometheus is a good strategic move that gives it a foothold in immunology
April 17, 2023
From MarketWatch
From InvestorPlace
From InvestorPlace
From Motley Fool
Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today?
April 17, 2023
From InvestorPlace
From Benzinga
What's Going On With Moderna Stock Monday?
April 17, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.